NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

COVID-19 Vaccine Response in Chronic Respiratory Conditions

CompletedN/A

Sponsor: National Jewish Health

Conditions: SARS-CoV Infection

Interventions: COVID-19 vaccine

Countries: United States

The investigators will assess the antibody, T cell and B cell responses to SARS-CoV-2 vaccination before and every 3 months for 18 months after the initial vaccination or subsequent vaccinations (boosters) in adults and children including patients with chronic medical conditions.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Receipt of a SARS-CoV-2 vaccination

Exclusion Criteria:

* None

Locations (1)

Denver, Colorado, United States